Cardiology practices across the nation are feeling the repercussions of their actions as the U.S. Attorney’s Office announces a massive $17.7 million settlement over allegations of overbilling Medicare. A total of 16 practices in 12 states were accused of inflating costs of diagnostic radiopharmaceuticals, which are used in cardiovascular imaging procedures.
The fraud allegations, which spanned over a decade in some instances, resulted in significant financial settlements from these practices, with Heart Clinic of Paris, P.A. and Arjumand Hashmi topping the list at $2.6 million, according to the Department of Justice. This comes as a stark reminder of the strict regulations governing Medicare reimbursements and the severe consequences for those who attempt to manipulate the system.
U.S. Attorney Graves expressed appreciation for the whistleblowers' role in bringing the matter to light, stating, “Practices and providers who overcharge the government and fail to return overpayments compromise our healthcare programs. So I applaud the whistleblowers who came forward in this case.” Their efforts have not gone unrewarded, with the whistleblowers set to receive approximately $2.2 million from the settlements, according to the U.S. Attorney's Office release.
The settlements highlight the ongoing battle against healthcare fraud, with Medicare providers expected to report honest and accurate expenses. “Medicare providers are required to be honest and accurate the costs they report for reimbursement,” said Special Agent in Charge Maureen Dixon, for the HHS-OIG. The Department of Health and Human Services encourages whistleblowers to continue reporting potential fraud by calling 800-HHS-TIPS, detailed by the U.S. Attorney's Office.
While these claims have been settled, it’s worth mentioning that these are allegations only, and no determination of liability has been made. The investigation was spearheaded by various agencies including the Justice Department’s Civil Division and the U.S. Attorney’s Offices for the District of Columbia and Western District of Kentucky, who have reiterated their commitment to ensuring the integrity of federal healthcare programs.
